Vivos (RDGL) Assets Growth (3y) (2013 - 2025)
Vivos (RDGL) Assets Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.33% |
| Sep 30, 2025 | 3.90% |
| Jun 30, 2025 | 35.81% |
| Mar 31, 2025 | 36.16% |
| Dec 31, 2024 | 10.97% |
| Sep 30, 2024 | -15.24% |
| Jun 30, 2024 | -7.46% |
| Mar 31, 2024 | -18.13% |
| Dec 31, 2023 | 19.75% |
| Sep 30, 2023 | 200.20% |
| Jun 30, 2023 | 81.45% |
| Dec 31, 2022 | 241.20% |
| Sep 30, 2022 | 118.16% |
| Jun 30, 2022 | 184.17% |
| Mar 31, 2022 | 183.63% |
| Dec 31, 2021 | 362.81% |
| Sep 30, 2021 | 458.51% |
| Jun 30, 2021 | 549.18% |
| Mar 31, 2021 | 1,443.53% |
| Dec 31, 2020 | 290.89% |